flumazenil has been researched along with Congenital Adrenal Hyperplasia in 2 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dumic, KK | 1 |
Grubic, Z | 1 |
Kusec, V | 1 |
Braovac, D | 1 |
Gotovac, K | 1 |
Vinkovic, M | 1 |
Vucinic, M | 1 |
Dumic, M | 1 |
Kocova, M | 1 |
Anastasovska, V | 1 |
Petlichkovski, A | 1 |
Falhammar, H | 1 |
2 other studies available for flumazenil and Congenital Adrenal Hyperplasia
Article | Year |
---|---|
The prevalence and genotype of 21-hydroxylase deficiency in the Croatian Romani population.
Topics: Adrenal Hyperplasia, Congenital; Croatia; Cross-Sectional Studies; Genotype; Humans; Prevalence; Rom | 2023 |
First insights into the genetics of 21-hydroxylase deficiency in the Roma population.
Topics: Adrenal Hyperplasia, Congenital; Genotype; Humans; Mutation; Roma; Steroid 21-Hydroxylase | 2021 |